|

AZD5335 Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: AZ14170132

Pipeline

Phase 1: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • AstraZeneca3

Indications

  • Cancer3
  • Ovarian Cancer2
  • Primary Peritoneal1
  • Fallopian Tube Cancer1
  • Lung Adenocarcinoma1

Other1 trial

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1

Duarte, California1 trial

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site

Phase 1/2

Fort Lauderdale, Florida1 trial

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.